Medfast Revenue and Competitors

Aliquippa, PA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Medfast's estimated annual revenue is currently $11.9M per year.(i)
  • Medfast's estimated revenue per employee is $201,000

Employee Data

  • Medfast has 59 Employees.(i)
  • Medfast grew their employee count by 4% last year.

Medfast's People

NameTitleEmail/Phone
1
Pharmacy TechnicianReveal Email/Phone
2
President/OwnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.6M2328%N/AN/A
#2
$84.2M4193%N/AN/A
#3
$14.1M700%N/AN/A
#4
$1224.3M6091-9%N/AN/A
#5
$43.2M215-4%N/AN/A
#6
$12.3M61-6%N/AN/A
#7
$19.9M9941%N/AN/A
#8
$16.5M82-5%N/AN/A
#9
$97.7M48630%N/AN/A
#10
$12.5M62-16%N/AN/A
Add Company

What Is Medfast?

"We are more than a Pharmacy, We are Family." We are a locally owned company and feel that it is important to give back to the areas that support us. Med-Fast's pharmacists and staff are dedicated to offering fast, friendly, and courteous service at a low cost. We offer Free Prescriptions, $4.00 generics and much more. Med-Fast Pharmacy is very thankful for all of our loyal customers, that is why we have enrolled a loyalty program RXtra Cash that puts money back in the pockets of our customers. Get 2% Cash back on all pharmacy purchases. Break the Large Drug Store chains and Support your Local Pharmacy. Store Hours: M-F 9:00am-7:00pm Saturday: 9:00am-4:00pm Sunday: 10:00am-2:00pm With over 13 locations, find a Med-Fast that is close to you. www.medfast.com

keywords:N/A

N/A

Total Funding

59

Number of Employees

$11.9M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Medfast News

2022-04-06 - MedSpeed Promotes Kent Creasman to Chief Commercial Officer

MedSpeed, the market-leading provider of same-day logistics services to the healthcare industry, has promoted Kent Creasman to Chief...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.8M6520%N/A
#2
$32.1M10015%N/A
#3
$27.3M1099%N/A
#4
$33.4M115-1%N/A
#5
$140.4M3505%N/A